An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 3 , ISSUE 3 ( September-December, 2011 ) > List of Articles

RESEARCH ARTICLE

Idiopathic Intracranial Hypertension: Changing Trends

Vivek Lal, Gopika Kalsotra, Vikas Saini

Keywords : Pseudotumor cerebri,BIH,Optic nerve fenestration

Citation Information : Lal V, Kalsotra G, Saini V. Idiopathic Intracranial Hypertension: Changing Trends. Int J Otorhinolaryngol Clin 2011; 3 (3):161-167.

DOI: 10.5005/jp-journals-10003-1076

Published Online: 01-12-2011

Copyright Statement:  Copyright © 2011; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Idiopathic intracranial hypertension (IIH) is a disorder of raised ICP without any obvious underlying brain pathology. Early intervention remains the key to success. The patients with BIH and vision threatening papilloedema should be taken up for optic nerve fenestration and the results are favorable in terms of visual outcome. The procedure is safe with few intraoperative or postoperative complications.


PDF Share
  1. Über meningitis serosa: Sammlung linische vortra 67. Inn Med 1893;23:655–94.
  2. Über falle vom symptomenkomplex ‘tumor cerebri’ mit ausgang in heilun (pseudotumor cerebri): Über letal verlaufene falle von ‘pseudotumor cerebri’ mit sektionsbefund. Deutsche Zeitschr für Nerven Heilkunde 1904;27:169–216.
  3. Benign forms of intracranial hypertension: Toxic and otitic hydrocephalus. Brain 1955;78:1–41.
  4. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989;46:1049–51.
  5. Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg 1937;106:492–513.
  6. Whence pseudotumor cerebri? J Clin Neuro-ophthalmol 1985;5:55–56.
  7. The incidence of pseudotumor cerebri: Population studies in Iowa and Louisiana. Arch Neurol 1988;45:875–77.
  8. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155–80.
  9. Idiopathic intracranial hypertension (pseudotumor cerebri): A reappraisal. Neurology 2001;7:2–67.
  10. Idiopathic intracranial hypertension in female homozygous twins. J Neurol Neurosurg Psychiatry 1997;62:652–54.
  11. A familial coincidence of pseudotumor cerebri and communicating hydrocephalus. Neurosurgery 1991;28:727–29.
  12. Pathogenesis of pseudotumor cerebri syndromes. Neurology 1981;31:877–80.
  13. Brain swelling of unknown cause. Neurology 1956;6:791–803.
  14. MR imaging of pseudotumor cerebri. AJR Am J Roentgenol 1988;150:903–09.
  15. Brain water accumulation in pseudotumour cerebri demonstrated by MRimaging of brain water self-diffusion. Acta Neurochir Suppl (Wien) 1990;51:363–65.
  16. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46:198–202.
  17. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995;45:1655–59.
  18. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990;10:331–35.
  19. Benign intracranial hypertension: Part II—CSF pressure and circulation. Brain 1974;97:301–12.
  20. Otologic manifestations of benign intracranial hypertension syndrome: Diagnosis and management. Laryngoscope 1987;97:1–17.
  21. Idiopathic intracranial hypertension without papilledema: A case-control study in a headache center. Neurology 1998;51:245–49.
  22. Idiopathic intracranial hypertension in a young child without visual symptoms or signs. Headache 1996;36:574–76.
  23. Benign intracranial hypertension. Medicine 1975;54:197–207.
  24. Idiopathic intracranial hypertension and seventh nerve palsy. Headache 1997;37: 286–88.
  25. Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy. J Neuroophthalmol 1998;18:53–55.
  26. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography (OCT) compared to clinical expert assessment using a clinical staging scale. Arch Ophthalmol 2010.
  27. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol 1987;44:170–75.
  28. Volume of the ventricles in benign intracranial hypertension. Lancet 1980;2:7–8.
  29. Pseudotumor cerebri: Clinical and neuroradiological findings. Eur Arch Psychiatry Neurol Sci 1987;237:54–60.
  30. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998;105:1686–93.
  31. MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 1996;38:769–73.
  32. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders Co. 1992.
  33. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094–98.
  34. Idiopathic intracranial hypertension: The association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007;7:15.
  35. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999;229:634–40.
  36. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 1966;25:430–36.
  37. The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974;189:194–201.
  38. Idiopathic intracranial hypertension. Neurol Clin 2010;28(3):593–617.
  39. Idiopathic intracranial hypertension. Ophthalmology 2007;114:617.
  40. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994;118:88–96.
  41. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983;10:221–29.
  42. The treatment of benign intracranial hypertension: A review of 134 cases. Surg Neurol 1981;16:218–24.
  43. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988;69:195–202.
  44. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993;43:1071–72.
  45. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46:1524–30.
  46. Efficacy of lumbo-peritoneal versus ventriculoperitoneal shunting for management of chronic hydrocephalus following aneurismal subarachnoid hemorrhage. Acta Neurochir (Wien) 2000;142:45–49.
  47. The reliability of the absent cistern sign in assessing LP shunt function. Can J Neurol Sci 1999;26:40–43.
  48. Surgical treatment of chronic papilledema in children. Br J Ophthalmol 1975;59:92–95.
  49. A surgical approach to plerocephalic disc edema. Trans Ophthalmol Soc UK 1969;89:669–90.
  50. Decompression of the optic nerve in benign intracranial hypertension. Trans Ophthalmol Soc UK 1976;96:427–29.
  51. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988;106:1378–83.
  52. Results of optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbitotomy approach. Arch Ophthalmol 1988;106:1391–97.
  53. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988;106:1384–90.
  54. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1991;112:177–85.
  55. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993;111:632–35.
  56. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 1989;107: 1743–54.
  57. Optic nerve sheath decompression: History, techniques, and indications. Int Ophthalmol Clin 1991;31: 71–81.
  58. Operative complications of optic nerve sheath decompression. Ophthalmology 1993;100:683–90.
  59. Endoscopic endonasal management of pseudotumor cerebri: Is it effective? Laryngoscope 2007;117(7):1138–42.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.